Cabaletta Bio (CABA) Total Current Liabilities (2018 - 2025)

Cabaletta Bio's Total Current Liabilities history runs 8 years deep, the most recent figure standing at $50.2 million for Q4 2025.

• On a quarterly basis, Total Current Liabilities rose 85.16% year-over-year to $50.2 million in Q4 2025; TTM through Dec 2025 was $50.2 million, a 85.16% increase from a year earlier, with the FY2025 full-year figure at $50.2 million, up 85.16% from the prior year.
• Total Current Liabilities climbed to $50.2 million in Q4 2025 per CABA's latest filing, from $45.7 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $50.2 million in Q4 2025 and bottomed at $4.0 million in Q1 2021.
• The 5-year median for Total Current Liabilities is $10.1 million (2022), against an average of $17.7 million.
• Across the five-year window, Total Current Liabilities retreated 3.69% in 2022 and jumped 132.08% in 2025, its largest moves.
• Year by year, Total Current Liabilities stood at $8.4 million in 2021, then grew by 13.23% to $9.5 million in 2022, then surged by 68.55% to $16.0 million in 2023, then surged by 69.35% to $27.1 million in 2024, then jumped by 85.16% to $50.2 million in 2025.
• Per Business Quant, the three latest CABA Total Current Liabilities figures stand at $50.2 million (Q4 2025), $45.7 million (Q3 2025), and $41.5 million (Q2 2025).